Provider News Posts
Let us know whether your clinic provides gender-affirming services!
2024-2025 nirsevimab (Beyfortus®) authorization guidelines
2024-2025 palivizumab (Synagis®) authorization guidelines
Watch for the Provider Appointment Availability Survey (PAAS), which will be coming to providers via email between September and November!
Your organization or practice may be eligible for the Alliance’s Data Sharing Incentive (DSI) program!
Effective Sept. 1, 2024, the Alliance will be implementing changes to the physician-administered drug benefit related to inflammatory bowel disease (IBD).
Raising the bar to increase access
The July 10 Child & Adolescent Vaccinations Lunch and Learn in collaboration with Merck & Co. has been cancelled.
Applications are now being accepted for the Data Sharing Support (DSS) Program. DSS Program grants will fund projects that support providers in sharing real-time health care data and connecting to a heath information exchange (HIE).
The Alliance will transition from to a new care management system called Jiva on July 15, 2024.
Meet our new Chief Health Equity Officer!
Contact Provider Services
| General | 831-430-5504 |
| Claims Billing questions, claims status, general claims information |
831-430-5503 |
| Authorizations General authorization information or questions |
831-430-5506 |
| Authorization Status Checking the status of submitted authorizations |
831-430-5511 |
| Pharmacy Authorizations, general pharmacy information or questions |
831-430-5507 |
